Mari Kitahata, MD, MPH

Professor
University of Washington
Seattle, WA

Disclosure: Nothing to disclose

Presentation(s):

• LB9 - The Effect of Initiating Integrase Inhibitor-based vs. Non-Nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy on Progression to Diabetes among North American Persons in HIV Care

  Friday, October 4
  1:55 PM – 2:05 PM